Xanthoma disseminatum: A case with hepatic involvement, diabetes insipidus and type IIb hyperlipidaemia

Clinical and Experimental Dermatology

Volumn 23, Issue 6, 1998, Pages 277-280

  Woollons, Arjida ^a   Darley, C R ^a  

^a Brighton Health Care NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; DESMOPRESSIN; FENOFIBRATE; STEROID;

ADULT; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES INSIPIDUS; HUMAN; HYPERLIPIDEMIA; INTRANASAL DRUG ADMINISTRATION; LIVER DISEASE; MACROPHAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIODIAGNOSIS; STEROID THERAPY; TREATMENT OUTCOME; XANTHOMA;

ADULT; DIABETES INSIPIDUS; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; HYPERLIPIDEMIAS; LIVER DISEASES; MALE;

EID: 0032438353     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1998.00347.x     Document Type: Article

References (18)

1. 1. Montgomery H, Osterberg AE. Xanthomatosis. Correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma. Arch Dermatol Syph 1938; 37: 373-402.
2. 2. Zelger BWH, Sidoroff A, Orchard G. Non-Langerhans cell histiocytoses. A new unifying concept. Am J Dermatopathol 1996; 18: 490-504.
3. 3. Zelger B, Cerio R, Orchard G et al. Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X. Arch Dermatol 1992; 128: 1207-12.
4. 4. Mullans EA, Helm TN, Taylor JS et al. Generalized non-Langerhans cell histiocytosis: Four cases illustrate a spectrum of disease. Int J Dermatol 1995; 34: 106-22.
5. 5. Gianotti F, Caputo R. Histiocytic syndromes: A review. J Am Acad Dermatol 1985; 13: 383-404.
6. 6. Ringel E, Moschella S. Primary histiocytic dermatoses. Arch Dermatol 1985; 121: 1531-41.
7. 7. Altman J, Winkelmann RK. Xanthoma disseminatum. Arch Dermatol 1962; 86: 62-76.
8. 8. Kalz F, Hoffman MM, Lafrance A. Xanthoma disseminatum: Clinical and laboratory observations over a ten year period. Dermatologica 1970; 140: 129-41.
9. 9. Caputo R, Veraldi S, Grimalt R et al. The various clinical patterns of xanthoma disseminatum. Dermatology 1995; 190: 19-24.
10. 10. Varotti C, Bettoli V, Berti F, et al. Xanthoma disseminatum: A case with extension mucous membrane involvement. J Am Acad Dermatol 1991; 25: 433-6.
11. 11. Hammond RR, Mackenzie IRA. Xanthoma disseminatum with massive intracranial involvement. Clin Neuropathol 1995; 14: 314-21.
12. 12. Knobler RM, Neumann RA, Gebhart W et al. Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary system. J Am Acad Dermatol 1990; 23: 341-6.
13. 13. Odell WD, Doggett RS. Xanthoma disseminatum, a rare cause of diabetes insipidus. J Clin Endocrinol Metabol 1993; 76: 777-80.
14. 14. Weiss N, Keller C. Xanthoma disseminatum: a rare normolipaemic xanthomatosis. Clin Invest 1993; 71: 233-8.
15. 15. Blobstein SH, Caldwell D, Carter M. Bone lesions in xanthoma disseminatum. Arch Dermatol 1985; 121: 1313-17.
16. 16. Frank SB, Weidman AI. Xanthoma disseminatum; an unusual form with extension of xanthomatosis changes into muscle. Arch Dermatol Syph 1952; 65: 88-94.
17. 17. Mishkel MA, Cockshott P, Nazir JD et al. Xanthoma disseminatum. Clinical, metabolic, pathologic and radiologic aspects. Arch Dermatol 1977; 113: 1094-100.
18. 18. Kumakiri M, Sudoh M, Miura Y. Xanthoma disseminatum. Report of a case, with histological and ultrastructural studies of skin lesions. J Am Acad Dermatol 1981; 4: 291-9.